Health Care Equipment & Services

CapSovision’s founder buys 2,022 shares at $7.58, signaling confidence in a rising stock amid new risk leadership and social‑media buzz.

ClearPoint Neuro CEO Joseph Burnett’s latest buy under a disciplined 10b‑5‑1 plan signals confidence in the company’s gene‑therapy platform—and a potential upside despite current valuation lows.

ELH’s insider incentive and FDA/CE clearance for RespirtTrack™ signal strong momentum—boosting investor confidence and offering clinicians a non‑invasive ARDS monitor poised to improve ICU outcomes.

Teladoc Health insider sale: 2,500 shares at $9.00—minor impact, but a key signal of executive liquidity strategy amid rapid virtual‑care growth.

Alignment Healthcare insider sales spike—investors analyze impact on high‑valuation tech stock and future strategic moves.

Novocure’s HR chief’s recent insider share purchase signals confidence amid a new German CE‑mark, offering insight into the company’s future prospects.

Explore Thor Kirk K’s latest insider buy at Integer Holdings—net‑buy momentum, strong financials, and a robust FDA‑cleared product pipeline signal potential upside for investors.

Last chapter of Select Medical Holdings’ merger: Scully Thomas sells remaining shares at $16.50, while insider sales and high sentiment signal a new era for investors.

Insider purchase shows confidence in Modular Medical’s pivot to commercializing its tubeless insulin pump—small trade, big signal for investors.

Alpha Tau CFO’s bulk sales amid a 30 % stock surge: why insider selling may signal personal wealth moves, not company trouble, and how the firm’s growing alpha‑emitter tech and regulatory wins keep its upside intact.